Candel Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $14k | 1.9k | 6.93 |
| 2024-06-30 | $12k | 1.9k | 6.20 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors